Many U.S. companies are grappling with health insurance coverage issues for workers when it comes to GLP-1 drugs for weight loss. Despite the hefty price tag â typically between $1,000 to $1,500 a month â consumers are clamoring for drugs like Novo Nordisk‘s Wegovy and Eli Lilly‘s Zepbound. This class of drugs, historically used to … Read more
Evercore ISI’s Julian Emanuel thinks Nvidia’s monster rally is fueling a fear of missing out in the market. He finds clients, including many who traded through the dot-com boom and subsequent collapse, are more worried about being underinvested than overexposed right now. “That’s the first time that’s happened since 2021 for us,” the firm’s senior … Read more
The Kingdom of Saudi Arabia (KSA) has been ranked third among Arab countries in obesity cases, after Kuwait and Qatar, local media reported. Dr Walid Al-Bakr, a diabetes and endocrinology consultant, recently revealed during a lecture the cases of obesity in the Kingdom are estimated at 35.4 percent. He also revealed that the Hail region … Read more
United Parcel Service — The stock continued lower Wednesday, one day after falling more than 8% on a disappointing 2024 revenue outlook and an announcement of 12,000 layoffs . Jim said, “I don’t know if [CEO] Carol Tome can keep the job.” The fact is, he added, e-commerce is very strong and “she’s not participating … Read more
A preliminary review of side effects from popular drugs used to treat diabetes and obesity shows no link with suicidal thoughts or actions, the U.S. Food and Drug Administration said Thursday. But the agency also said officials cannot definitively rule out that “a small risk may exist” and that they’ll continue to look into reports … Read more
As the winter blues set in for many in Canada, experts say feelings of depression can lead people to gain weight, with new research suggesting that the risk of weight increases in the short term are higher in people who are already obese. A study by University of Cambridge scientists published in the PLOS ONE … Read more
WASHINGTON — New obesity drugs are showing promising results in helping some people shed pounds but the injections will remain out of reach for millions of older Americans because Medicare is forbidden to cover such medications. Drugmakers and a wide-ranging and growing bipartisan coalition of lawmakers are gearing up to push for that to change … Read more
NEW YORK — A new study adds to evidence that severe obesity is becoming more common in young U.S. children. There was some hope that children in a government food program might be bucking a trend in obesity rates — earlier research found rates were dropping a little about a decade ago for those kids. … Read more
